A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Morgensztern, MD
Washington University School of Medicine in St. Louis
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Arizona Cancer Center
Tucson, Arizona, United States
- Uc San Diego
La Jolla, California, United States
- Brrh Lynn Cancer Institute
Boca Raton, Florida, United States
- Memorial Cancer Institute
Pembroke Pines, Florida, United States
- Horizon Oncology Research
Lafayette, Indiana, United States
- Ashland-Bellefonte Cancer Center
Ashland, Kentucky, United States
- Baptist Health Louisville
Louisville, Kentucky, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- New York Oncology Hematology
Albany, New York, United States
- Winthrop Hospital
Mineola, New York, United States
- Oncology Hematology Care, Inc.
Cincinnati, Ohio, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- Providence Portland Medical Center
Portland, Oregon, United States
- University of Pennsylvania
Philadelphia, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- Virginia Cancer Specialists
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Apr 2015
- Primary completion
- 3 May 2021
- Completion
- 4 Nov 2022
- Last update posted
- 21 Sept 2023
- Registered enrollment
- 121
- Registry id
- NCT02439450
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.